White & Case Advises Caprion Biosciences on Acquisition of Immune Monitoring Laboratory from ImmuneHealth
Global law firm White & Case LLP has advised Caprion Biosciences Inc., the leading provider of proteomics and immune monitoring services to the pharmaceutical and biotechnology industry, on the acquisition of the immune monitoring laboratory assets of ImmuneHealth ASBL, located in Gosselies, Belgium.
The ImmuneHealth laboratory was established by the Université Libre de Bruxelles and GSK and will provide Caprion, which was acquired in July 2016 by European specialist investor in healthcare GHO Capital Partners LLP, with a fully operational laboratory, expertise, track record and network. Caprion has announced it will continue to operate from its headquarters in Montreal as well as from its new location in Belgium, and will continue to expand its capabilities on a European and global scale.
"We advised Caprion on this first acquisition following its recapitalization by GHO, and which completed shortly after the conclusion of a partnership agreement between the Province of Quebec and the Walloon Region," said Brussels-based White & Case partner Thierry Bosly, who led the Firm's deal team.
The White & Case team in Brussels which advised on the transaction was led by partner Thierry Bosly and included local partner Muriel Alhadeff and associates Laurent Lantonnois, Thomas Glauden, Aurélie Terlinden and Morgane van Ermengem. The White & Case team worked in conjunction with Osler, Hoskin & Harcourt.
For more information, please speak to your local media contact.